Gladstone Institutional Advisory’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,630	Closed	-$228K	–	714
2022 Q1	$228K	Buy	9,630 +2,124	+28%	+$50.3K	0.02%	630
2021 Q4	$257K	Buy	+7,506	New	+$257K	0.02%	512